Drug profile · INN
etelcalcetide hydrochloride
PARSABIV
etelcalcetide hydrochloride (PARSABIV) is a calcium sensing receptor agonist.
PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — etelcalcetide hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
etelcalcetide hydrochloride (PARSABIV) is a calcium sensing receptor agonist.
Key facts
INN etelcalcetide hydrochloride
Brand PARSABIV
Mechanism Calcium sensing receptor agonist
Target Extracellular calcium-sensing receptor
Mechanism of action
Calcium sensing receptor agonist
Primary target: Extracellular calcium-sensing receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is etelcalcetide hydrochloride?
etelcalcetide hydrochloride (PARSABIV) is a calcium sensing receptor agonist.
What is the brand name for etelcalcetide hydrochloride?
PARSABIV is a marketed brand name for etelcalcetide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.